In addition to these lipid metabolic changes, decreased cell proliferation, migration, and invasion, as well as the inhibition of xenografted tumor growth, were also observed, consistent with the correlation between high GPD1 protein levels and better ccRCC patient survival. This evidence concerns the gene GPD1 and nonpapillary renal cell carcinoma.